unknown
Stage
About
Alamar Bio develops a highly sensitive, fully automated multiplex proteomics platform capable of profiling thousands of proteins from minimal blood samples to enable discovery and clinical use of protein biomarkers for disease detection and research.
Explore Alamar Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.